BIO-key International Enters into $2.5 Million Warrant Inducement Transaction

HOLMDEL, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq:BKYI), a global innovator in Identity and Access Management (IAM) and biometric authentication solutions, today announced it has entered into a warrant inducement agreement with an existing institutional investor for the exercise of certain outstanding warrants that the Company issued on October 28, 2025 (the “Warrants”). Pursuant to the warrant inducement agreement, the investor has agreed to exercise the Warrants to purchase an aggregate of 618,334 shares of the Company's common stock at a reduced exercise price of $4.06 per share, subject to compliance with beneficial ownership blocker provisions included in the Warrants. The gross proceeds from the exercise of the Warrants are expected to be approximately $2.5 million, prior to deducting placement agent fees and estimated offering expenses.